Provided by Tiger Fintech (Singapore) Pte. Ltd.

Glaukos

93.12
-1.0300-1.09%
Volume:92.97K
Turnover:8.70M
Market Cap:5.34B
PE:-56.33
High:94.18
Open:94.05
Low:93.07
Close:94.15
52wk High:163.71
52wk Low:77.10
Shares:57.35M
Float Shares:55.40M
Volume Ratio:0.37
T/O Rate:0.17%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6531
EPS(LYR):-2.7746
ROE:-12.98%
ROA:-6.34%
PB:6.98
PE(LYR):-33.56

Loading ...

Stifel Nicolaus Keeps Their Buy Rating on Glaukos (GKOS)

TIPRANKS
·
Jul 08

Glaukos Corporation Secures EU MDR Certification for iStent infinite® and Leading MIGS Therapies, Marking First Approvals Under New EU Regulatory Framework

Reuters
·
Jun 26

Glaukos Positioned for Growth with Innovative Epioxa Therapy and First-Mover Advantage in Keratoconus Treatment

TIPRANKS
·
Jun 17

Glaukos Stockholders Approve Key Proposals at Annual Meeting

TIPRANKS
·
Jun 04

Glaukos Corporation Conducted Annual Stockholders Meeting

Reuters
·
Jun 04

Top Research Reports for Meta Platforms, Broadcom & JPMorgan

Zacks
·
Jun 04

Glaukos Is Maintained at Underweight by Morgan Stanley

Dow Jones
·
May 06

Glaukos Is Maintained at Overweight by Stephens & Co.

Dow Jones
·
May 03

Stock Track | Glaukos Surges 5% as Q1 Earnings Beat Expectations, Revenue Jumps 25%

Stock Track
·
May 03

Glaukos First Quarter 2025 Earnings: Beats Expectations

Simply Wall St.
·
May 02

Glaukos falls -15.3%

TIPRANKS
·
May 02

Glaukos Price Target Cut to $135.00/Share From $140.00 by Truist Securities

Dow Jones
·
May 01

GKOS Stock Falls Despite Q1 Earnings & Revenue Beat, Margins Decline

Zacks
·
May 01

Q1 2025 Glaukos Corp Earnings Call

Thomson Reuters StreetEvents
·
May 01

Truist Adjusts Price Target on Glaukos Corp to $135 From $140, Maintains Buy Rating

MT Newswires Live
·
May 01

Stock Track | Glaukos Plummets 11.62% as Multiple Analysts Slash Price Targets and Wells Fargo Downgrades

Stock Track
·
May 01

Glaukos Cut to Equal-Weight From Overweight by Wells Fargo

Dow Jones
·
May 01

Glaukos price target lowered to $135 from $140 at Truist

TIPRANKS
·
May 01

Glaukos Is Maintained at Buy by Needham

Dow Jones
·
May 01

Wells downgrades Glaukos with iDose growth priced in

TIPRANKS
·
May 01